Multi-centre, open label, randomized phase I/II clinical of the use of REX-002 in chronic critical limb ischemia non-diabetes patients

Trial Profile

Multi-centre, open label, randomized phase I/II clinical of the use of REX-002 in chronic critical limb ischemia non-diabetes patients

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 10 Aug 2016

At a glance

  • Drugs REX 002 (Primary)
  • Indications Peripheral ischaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top